Xiang Qiwang, Wouters Camille, Chang Peixi, Lu Yu-Ning, Liu Mingming, Wang Haocheng, Yang Junqin, Pekosz Andrew, Zhang Yanjin, Wang Jiou
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
Department of Molecular Microbiology & Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
bioRxiv. 2024 Dec 5:2024.12.04.624804. doi: 10.1101/2024.12.04.624804.
SARS-CoV-2 infection poses a major threat to public health, and understanding the mechanism of viral replication and virion release would help identify therapeutic targets and effective drugs for combating the virus. Herein, we identified E3 ubiquitin-protein ligase Itchy homolog (ITCH) as a central regulator of SARS-CoV-2 at multiple steps and processes. ITCH enhances the ubiquitination of viral envelope and membrane proteins and mutual interactions of structural proteins, thereby aiding in virion assembly. ITCH-mediated ubiquitination also enhances the interaction of viral proteins to the autophagosome receptor p62, promoting their autophagosome-dependent secretion. Additionally, ITCH disrupts the trafficking of the protease furin and the maturation of cathepsin L, thereby suppressing their activities in cleaving and destabilizing the viral spike protein. Furthermore, ITCH exhibits robust activation during the SARS-CoV-2 replication stage, and SARS-CoV-2 replication is significantly decreased by genetic or pharmacological inhibition of ITCH. These findings provide new insights into the mechanisms of the SARS-CoV-2 life cycle and identify a potential target for developing treatments for the virus-related diseases.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对公众健康构成重大威胁,了解病毒复制和病毒粒子释放的机制将有助于确定对抗该病毒的治疗靶点和有效药物。在此,我们确定E3泛素蛋白连接酶Itchy同源物(ITCH)是SARS-CoV-2在多个步骤和过程中的核心调节因子。ITCH增强病毒包膜和膜蛋白的泛素化以及结构蛋白的相互作用,从而有助于病毒粒子的组装。ITCH介导的泛素化还增强了病毒蛋白与自噬体受体p62的相互作用,促进它们依赖自噬体的分泌。此外,ITCH破坏蛋白酶弗林蛋白酶的运输和组织蛋白酶L的成熟,从而抑制它们在切割和破坏病毒刺突蛋白中的活性。此外,ITCH在SARS-CoV-2复制阶段表现出强烈激活,通过基因或药物抑制ITCH可显著降低SARS-CoV-2复制。这些发现为SARS-CoV-2生命周期的机制提供了新见解,并确定了一个开发针对病毒相关疾病治疗方法的潜在靶点。